Trump Administration's NIH Grant Funding Controversy

The Trump administration has agreed to review previously frozen health research grants without applying its controversial diversity, equity, and inclusion (DEI) standards. This decision follows a settlement reached in a Massachusetts federal court on December 29, 2025, involving the National Institutes of Health (NIH) and a coalition of Democratic attorneys general from 17 states, including Massachusetts, California, and New York. The NIH will evaluate grant applications submitted until September 29, 2025, through its standard scientific review process, excluding the previously imposed DEI criteria.

Trump Administration Removes Anti-DEI Criteria from Health Research GrantsGovernment ExecutiveBoston GlobeInside Higher EdNew York Times

The settlement stems from a legal challenge initiated in April 2025 concerning $783 million in frozen grants. A trial court and an appeals court in Massachusetts had sided with the states, but the U.S. Supreme Court ruled in August that the trial judge lacked the authority to compel the issuance of these grants. The appeals court's unanimous decision reaffirmed that the Trump administration's attempts to impose drastic cuts to NIH funding were unlawful, particularly regarding indirect cost reimbursement rates for universities and research institutions.

Inside Higher Ed

The Trump administration had sought to cap indirect costs for research grants at 15%, significantly lower than the previously negotiated rates, which often exceeded 30-40%. This cap would have resulted in over $4 billion in annual savings for the NIH but threatened to cripple funding for essential research, including studies on cancer and infectious diseases. Experts, including Dr. Paul Anderson from Mass General Brigham, emphasized that such cuts would undermine life-saving innovations and patient care.

New York Times

Critics of the Trump administration's funding policies have expressed concern over the potential for future appeals to the Supreme Court, which could further jeopardize research funding. Dr. David Christiani from Harvard Medical School highlighted the precariousness of federal funding, stating that his laboratory would have faced significant financial losses without judicial intervention. Massachusetts Attorney General Andrea Joy Campbell noted that while the settlement is a positive step, it does not resolve all issues stemming from the administration's funding strategies.

Boston Globe

Massachusetts Attorney General Andrea Joy Campbell stated that the agreement commits the Department of Health and Human Services to resume the usual process for considering NIH grant applications on a prompt timeline. In contrast, White House spokesperson Kush Desai defended the administration's previous funding cuts as efforts to eliminate "waste, fraud, and abuse" in government spending.

Government Executive

The future of NIH funding remains uncertain as the Trump administration has not fully abandoned its evaluation strategy based on DEI. Legal experts, including David Super from Georgetown Law, anticipate that the administration may petition the Supreme Court to hear the case, which could lead to further developments in the ongoing conflict over federal research funding policies.

Boston Globe

• “the usual process for considering NIH grant applications on a prompt, agreed-upon timeline.” — Andrea Joy Campbell, Massachusetts Attorney General

Government Executive

• “fifteen percent would be the death of everything. We can’t survive as institutions on that low of a number.” — Dr. Bruce Fischl, Harvard Medical School

Boston Globe

• “Contrary to the hysteria, redirecting billions of allocated NIH spending away from administrative bloat means there will be more money and resources available for legitimate scientific research, not less,” — Kush Desai, White House Spokesperson

Boston Globe